Slow proliferation as a biological feature of colorectal cancer metastasis

被引:38
作者
Anjomshoaa, A. [1 ]
Nasri, S. [1 ]
Humar, B. [1 ]
McCall, J. L. [2 ]
Chatterjee, A. [1 ]
Yoon, H-S [3 ]
McNoe, L. [4 ]
Black, M. A. [1 ]
Reeve, A. E. [1 ]
机构
[1] Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, New Zealand
[2] Univ Auckland, Dept Surg, Auckland 1, New Zealand
[3] Univ Otago, Dept Pathol, Otago, New Zealand
[4] Univ Otago, Dept Biochem, Otago Genom Facil, Otago, New Zealand
关键词
colorectal cancer; proliferation; liver metastasis; LIVER METASTASES; COLON-CANCER; CELL-PROLIFERATION; EXPRESSION; ADENOCARCINOMAS; ANEUPLOIDY; SIGNATURE; PROGNOSIS; CARCINOMA; STAGE;
D O I
10.1038/sj.bjc.6605229
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
BACKGROUND: We have recently reported an inverse relationship between colon cancer progression and tumour proliferative activity. Here, we extend our findings by evaluating the proliferative activity of liver metastatic lesions and primary colorectal cancers (CRC) that differ in their metastatic potential. METHODS: Using an earlier established multi-gene proliferation signature (GPS), proliferative levels were analysed in 73 primary CRCs and 27 liver metastases. RESULTS: Compared with primary CRCs, we observed a significantly lower expression of the GPS in liver metastases and confirmed their lower proliferative levels by quantitative RT-PCR and Ki-67 immunostaining. No difference could be detected in apoptotic indices as assessed by M30 immunostaining, indicating that the net growth rate is lower in metastases relative to primary tumours. Notably, relapsed primaries or those with established metastases had significantly lower proliferative activity than CRCs that were non-metastatic and did not relapse. CONCLUSION: Our results suggest that slow proliferation is a biological characteristic of both liver metastases and those primary tumours with the ability to metastasise. The delineation of the mechanisms underlying the inverse association between proliferation and CRC aggressiveness may be important for the development of new therapeutic strategies. British Journal of Cancer ( 2009) 101, 822-828. doi:10.1038/sj.bjc.6605229 www.bjcancer.com Published online 4 August 2009 (C) 2009 Cancer Research UK
引用
收藏
页码:822 / 828
页数:7
相关论文
共 28 条
[1]
Regional treatment of metastasis: surgery of colorectal liver metastases [J].
Adam, R ;
Vinet, E .
ANNALS OF ONCOLOGY, 2004, 15 :103-106
[2]
Agui T, 2002, ANTICANCER RES, V22, P1769
[3]
Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer [J].
Anjomshoaa, A. ;
Lin, Y-H ;
Black, M. A. ;
McCall, J. L. ;
Humar, B. ;
Song, S. ;
Fukuzawa, R. ;
Yoon, H. -S ;
Holzmann, B. ;
Friederichs, J. ;
Van Rij, A. ;
Thompson-Fawcett, M. ;
Reeve, A. E. .
BRITISH JOURNAL OF CANCER, 2008, 99 (06) :966-973
[4]
DNA ploidy status and prognosis in colorectal cancer: A meta-analysis of published data [J].
Araujo, Sergio E. A. ;
Bernardo, Wanderley M. ;
Habr-Gama, Angelita ;
Kiss, Desiderio R. ;
Cecconello, Ivan .
DISEASES OF THE COLON & RECTUM, 2007, 50 (11) :1800-1810
[5]
Biology of colorectal liver metastases: A review [J].
Bird, Nigel C. ;
Mangnall, David ;
Majeed, Ali W. .
JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (01) :68-80
[6]
How dysregulated colonic crypt dynamics cause stem cell overpopulation and initiate colon cancer [J].
Boman, Bruce M. ;
Fields, Jeremy Z. ;
Cavanaugh, Kenneth L. ;
Guetter, Arthur ;
Runquist, Olaf A. .
CANCER RESEARCH, 2008, 68 (09) :3304-3313
[7]
Opinion - Migrating cancer stem cells - an integrated concept of malignant tumour progression [J].
Brabletz, T ;
Jung, A ;
Spaderna, S ;
Hlubek, F ;
Kirchner, T .
NATURE REVIEWS CANCER, 2005, 5 (09) :744-749
[8]
SNOMAD (Standardization and NOrmalization of MicroArray Data): web-accessible gene expression data analysis [J].
Colantuoni, C ;
Henry, G ;
Zeger, S ;
Pevsner, J .
BIOINFORMATICS, 2002, 18 (11) :1540-1541
[9]
Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma [J].
D'Arrigo, A ;
Belluco, C ;
Ambrosi, A ;
Digito, M ;
Esposito, G ;
Bertola, A ;
Fabris, M ;
Nofrate, V ;
Mammano, E ;
Leon, A ;
Nitti, D ;
Lise, M .
INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (02) :256-262
[10]
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients [J].
Dai, HY ;
van't Veer, L ;
Lamb, J ;
He, YD ;
Mao, M ;
Fine, BM ;
Bernards, R ;
de Vijver, MV ;
Deutsch, P ;
Sachs, A ;
Stoughton, R ;
Friend, S .
CANCER RESEARCH, 2005, 65 (10) :4059-4066